Cargando…
Performance evaluation of a rapid whole-blood immunoassay for the detection of IgG antibodies against Helicobacter pylori in daily clinical practice
BACKGROUND: A growing number of rapid Helicobacter pylori antibody tests are commercially available now, however, some of these tests are often used without sufficient evaluation. The aim of this study was to evaluate the performance of a commercially available rapid whole-blood immunoassay (gabCont...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977652/ https://www.ncbi.nlm.nih.gov/pubmed/27503600 http://dx.doi.org/10.1186/s12941-016-0161-1 |
_version_ | 1782447069354524672 |
---|---|
author | Enko, Dietmar Halwachs-Baumann, Gabriele Stolba, Robert Rössler, Ortrun Kriegshäuser, Gernot |
author_facet | Enko, Dietmar Halwachs-Baumann, Gabriele Stolba, Robert Rössler, Ortrun Kriegshäuser, Gernot |
author_sort | Enko, Dietmar |
collection | PubMed |
description | BACKGROUND: A growing number of rapid Helicobacter pylori antibody tests are commercially available now, however, some of these tests are often used without sufficient evaluation. The aim of this study was to evaluate the performance of a commercially available rapid whole-blood immunoassay (gabControl(®)H. pylori; gabmed GmbH, Köln, Germany), for the qualitative detection of IgG antibodies against H. pylori with the (13)C-urea breath test ((13)C-UBT) serving as a reference method. METHODS: A total of 108 consecutive outpatients, who were referred for (13)C-UBT by general practitioners and specialists, were also tested for H. pylori infection by the gabControl(®)H. pylori immunoassay. The clinical performance of this rapid whole-blood test was evaluated by determining the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) compared to the (13)C-UBT. The agreement between the two tests was calculated using Cohen’s Kappa (κ) with 95 % confidence intervals (CI). RESULTS: The agreement between the gabControl(®)H. pylori assay and the (13)C-UBT was 0.62 [95 % confidence intervals (CIs) 0.47–0.76; P < 0.001]. With the (13)C-UBT serving as the non-invasive gold standard method of H. pylori diagnosis, the gabControl(®)H. pylori assay demonstrated a sensitivity and specificity of 91.4 and 76.7 %, respectively, with a PPV of 65.3 % and a NPV of 94.9 %. Seventeen (15.7 %) individuals with a positive H. pylori anamnesis showed a negative (13)C-UBT and were typed positive by the gabControl(®)H. pylori assay. Of these, 13 (76.5 %) and 3 individuals (17.6 %) had completed one and two eradication therapies, respectively. CONCLUSIONS: The gabControl(®)H. pylori immunoassay is a rapid and easy to use first line screening tool for H. pylori IgG antibody detection in daily clinical practice. However, this assay should not be used for confirmation of the successful H. pylori eradication after antibiotic treatment. |
format | Online Article Text |
id | pubmed-4977652 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-49776522016-08-10 Performance evaluation of a rapid whole-blood immunoassay for the detection of IgG antibodies against Helicobacter pylori in daily clinical practice Enko, Dietmar Halwachs-Baumann, Gabriele Stolba, Robert Rössler, Ortrun Kriegshäuser, Gernot Ann Clin Microbiol Antimicrob Research BACKGROUND: A growing number of rapid Helicobacter pylori antibody tests are commercially available now, however, some of these tests are often used without sufficient evaluation. The aim of this study was to evaluate the performance of a commercially available rapid whole-blood immunoassay (gabControl(®)H. pylori; gabmed GmbH, Köln, Germany), for the qualitative detection of IgG antibodies against H. pylori with the (13)C-urea breath test ((13)C-UBT) serving as a reference method. METHODS: A total of 108 consecutive outpatients, who were referred for (13)C-UBT by general practitioners and specialists, were also tested for H. pylori infection by the gabControl(®)H. pylori immunoassay. The clinical performance of this rapid whole-blood test was evaluated by determining the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) compared to the (13)C-UBT. The agreement between the two tests was calculated using Cohen’s Kappa (κ) with 95 % confidence intervals (CI). RESULTS: The agreement between the gabControl(®)H. pylori assay and the (13)C-UBT was 0.62 [95 % confidence intervals (CIs) 0.47–0.76; P < 0.001]. With the (13)C-UBT serving as the non-invasive gold standard method of H. pylori diagnosis, the gabControl(®)H. pylori assay demonstrated a sensitivity and specificity of 91.4 and 76.7 %, respectively, with a PPV of 65.3 % and a NPV of 94.9 %. Seventeen (15.7 %) individuals with a positive H. pylori anamnesis showed a negative (13)C-UBT and were typed positive by the gabControl(®)H. pylori assay. Of these, 13 (76.5 %) and 3 individuals (17.6 %) had completed one and two eradication therapies, respectively. CONCLUSIONS: The gabControl(®)H. pylori immunoassay is a rapid and easy to use first line screening tool for H. pylori IgG antibody detection in daily clinical practice. However, this assay should not be used for confirmation of the successful H. pylori eradication after antibiotic treatment. BioMed Central 2016-08-08 /pmc/articles/PMC4977652/ /pubmed/27503600 http://dx.doi.org/10.1186/s12941-016-0161-1 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Enko, Dietmar Halwachs-Baumann, Gabriele Stolba, Robert Rössler, Ortrun Kriegshäuser, Gernot Performance evaluation of a rapid whole-blood immunoassay for the detection of IgG antibodies against Helicobacter pylori in daily clinical practice |
title | Performance evaluation of a rapid whole-blood immunoassay for the detection of IgG antibodies against Helicobacter pylori in daily clinical practice |
title_full | Performance evaluation of a rapid whole-blood immunoassay for the detection of IgG antibodies against Helicobacter pylori in daily clinical practice |
title_fullStr | Performance evaluation of a rapid whole-blood immunoassay for the detection of IgG antibodies against Helicobacter pylori in daily clinical practice |
title_full_unstemmed | Performance evaluation of a rapid whole-blood immunoassay for the detection of IgG antibodies against Helicobacter pylori in daily clinical practice |
title_short | Performance evaluation of a rapid whole-blood immunoassay for the detection of IgG antibodies against Helicobacter pylori in daily clinical practice |
title_sort | performance evaluation of a rapid whole-blood immunoassay for the detection of igg antibodies against helicobacter pylori in daily clinical practice |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977652/ https://www.ncbi.nlm.nih.gov/pubmed/27503600 http://dx.doi.org/10.1186/s12941-016-0161-1 |
work_keys_str_mv | AT enkodietmar performanceevaluationofarapidwholebloodimmunoassayforthedetectionofiggantibodiesagainsthelicobacterpyloriindailyclinicalpractice AT halwachsbaumanngabriele performanceevaluationofarapidwholebloodimmunoassayforthedetectionofiggantibodiesagainsthelicobacterpyloriindailyclinicalpractice AT stolbarobert performanceevaluationofarapidwholebloodimmunoassayforthedetectionofiggantibodiesagainsthelicobacterpyloriindailyclinicalpractice AT rosslerortrun performanceevaluationofarapidwholebloodimmunoassayforthedetectionofiggantibodiesagainsthelicobacterpyloriindailyclinicalpractice AT kriegshausergernot performanceevaluationofarapidwholebloodimmunoassayforthedetectionofiggantibodiesagainsthelicobacterpyloriindailyclinicalpractice |